Clinical courses in multiple sclerosis

Multiple sclerosis is a highly variable disease. In this video, Dr Fred Lublin discusses the different clinical courses of MS

Dr. Lublin has disclosed that he is/was a grant/research support recipient for Novartis Pharmaceuticals Corp, Teva Neuroscience, Actelion, Transparency Life Sciences, NMSS, Sanofi and that he was/is a consultant/advisor for Biogen, EMD Serono, Novartis, Teva, Actelion, Sanofi/Genzyme, Acorda, Roche/Genetech, MedImmune, Receptos/Celgene, Forward Pharma, TG Therapeutics, Abbvie, Regeneron, Medday, Atara Biotherapeutics, Polpharma, Mapi Pharma, Innate Immunotherapeutics, Apitope, Orion Biotechnology, Brainstorm Cell Therapeutics, Jazz Pharmaceuticals, GW Pharma